Semax 10mg Pen

Price range: Rp1,600,000.00 through Rp2,200,000.00 ~$96.97–$133.33

Semax 10mg Pen is a convenient, ready-to-use peptide commonly associated with focus, mental clarity, and cognitive performance.
No mixing required — simple and easy to use.

✔ No mixing required
✔ Easy-to-use pen
✔ Focus & clarity support
✔ Fast Bali delivery

10 Needles + 10 Alcohol pads included.
Description

Semax 30 mg Pen

Product Description

Semax is a synthetic neuroactive heptapeptide derived from adrenocorticotropic hormone (ACTH)-fragment research and studied primarily for its potential effects on neuroplasticity, cognitive signalling, neuroprotection, stress-response biology, and monoaminergic neurotransmission.

Unlike full ACTH, Semax is described in the supplied research material as producing neurological signalling effects without significantly stimulating adrenal corticosteroid production. Experimental research has examined its influence on brain-derived neurotrophic factor (BDNF), dopamine, serotonin, synaptic plasticity, neuronal survival, and stress-related gene expression. Pasted text

The source characterizes Semax as having limited human clinical investigation alongside animal and in-vitro research, including studies involving cognition and neurological recovery. Pasted text

The Atlas Longevity Semax pen contains 30 mg in a 3 mL cartridge with 300 total units/clicks.

Semax remains an investigational neuropeptide and should not be presented as an approved treatment for stroke, cognitive impairment, anxiety, depression, neurological injury, or other medical conditions.


Clinical / Research Status

The supplied material describes Semax as having been studied in cognitive and neuroprotective research settings, including regional clinical applications, while much of the supporting evidence remains animal or mechanistic. Pasted text

Evidence Type Status Based on Supplied Material
Human clinical research Limited / regional
Human observational research Yes
Animal research Yes
In-vitro research Yes
Broad regulatory therapeutic approval Not established by supplied material

The source indicates some human clinical work, but the reference list supplied later is predominantly animal, in-vitro, or observational. For that reason, Atlas content should avoid overstating the strength of controlled human evidence.


Evidence Type

The supplied research includes:

  • neurological clinical studies;
  • ischemic stroke research;
  • rat cerebral-ischemia models;
  • hippocampal neurotrophic-factor studies;
  • cognitive-performance research;
  • chronic-stress animal models;
  • neuronal cell cultures;
  • optic-nerve research. Pasted text

The evidence base therefore combines clinical observations with substantial preclinical research.


Mechanism of Action

Semax is studied primarily for its potential effects on neurotrophic signalling and monoaminergic neurotransmission.

The supplied material describes several proposed mechanisms:

  • increased BDNF-related signalling;
  • modulation of neuronal survival pathways;
  • changes in synaptic plasticity;
  • effects on dopamine signalling;
  • effects on serotonin pathways;
  • changes in stress-related gene expression;
  • neuroimmune and inflammatory modulation. Pasted text

BDNF and Neuroplasticity

BDNF is a neurotrophic factor involved in neuronal survival, synaptic adaptation, and plasticity.

Experimental Semax research has reported changes in BDNF expression, providing one of the central mechanistic rationales for cognitive and neuroprotective investigation.

Monoaminergic Signalling

Semax has also been investigated for effects on dopamine and serotonin systems, particularly under stress or neurological challenge.

ACTH-Related Structure Without Full ACTH Activity

Although Semax originates from ACTH-fragment research, the source describes it as lacking the corticosteroid-stimulating activity associated with full ACTH.

This distinction allows researchers to investigate neurological pathways without relying on full endocrine ACTH activity. Pasted text


Potential Benefits / Research Areas

Neurotrophic-Factor Research

One of the major research areas for Semax involves BDNF and related neurotrophic pathways.

The supplied material reports increased BDNF expression in experimental models and links this with:

  • neuronal survival;
  • dendritic signalling;
  • synaptic plasticity;
  • learning-related pathways. Pasted text

These findings should not be presented as guaranteed cognitive improvement in humans.

Synaptic Plasticity and Memory Research

Semax has been investigated in models involving:

  • memory consolidation;
  • executive function;
  • attention;
  • learning-related signalling;
  • synaptic adaptation.

The source discusses CREB-associated pathways and changes in synaptic density in experimental research. Pasted text

Dopamine and Serotonin Research

The supplied material describes Semax as influencing dopamine and serotonin turnover.

These monoamine systems participate in attention, motivation, mood, reward, and stress-response biology. Pasted text

This does not establish Semax as a treatment for depression, ADHD, or other psychiatric disorders.

Ischemia and Neuroprotection Research

Semax has been investigated in experimental models of cerebral ischemia.

The source reports findings involving:

  • neuronal survival;
  • infarct-related measurements;
  • oxidative-stress markers;
  • glutamate-related excitotoxicity;
  • neurological recovery. Pasted text

Most mechanistic evidence remains preclinical, and Semax should not be presented as an established stroke therapy based on the supplied information.

Gene-Expression Research

Gene-expression studies referenced by the source describe changes in:

  • inflammatory mediators;
  • stress-response proteins;
  • neuronal signalling pathways;
  • neurotrophic factors. Pasted text

This makes Semax relevant to experimental neuroimmune and neuroplasticity research.

Cognitive Resilience Under Stress

Semax has also been investigated in acute and chronic stress models.

The supplied material describes changes in cognitive performance and behavioural outcomes under stress exposure. Pasted text

This should be described as research into cognitive resilience rather than guaranteed enhancement.

Neuroendocrine Selectivity Research

The source highlights the fact that Semax does not appear to produce the same corticosteroid stimulation as full ACTH.

This has made it useful in research attempting to separate ACTH-fragment neurological signalling from adrenal endocrine stimulation. Pasted text


Research Data

Study / Model Reported Finding
Ischemic stroke clinical research Improved neurological-recovery measures and reduced progression markers reported by source
Rat middle cerebral artery occlusion Reduced infarct-related measurements and increased neuronal-survival markers
Rat hippocampal tissue Increased BDNF and NGF-related expression
Healthy human cognitive research Changes in attention, memory consolidation and performance under fatigue
Chronic-stress rodent models Reduced anxiety-related behaviours and changes in HPA-axis activity
In-vitro neuronal culture Changes in dopamine/serotonin signalling and oxidative-stress resistance
Optic-nerve models Increased retinal ganglion-cell survival and visual-response markers

These findings span clinical and preclinical research and should not all be interpreted as established human therapeutic outcomes. Pasted text


Potential Stack / Combination Research

The supplied source discusses experimental combinations involving:

  • Semax + Selank;
  • Semax + Cerebrolysin;
  • Semax + NAD+;
  • Semax + Dihexa. Pasted text

The proposed research rationale involves combining neurotrophic, stress-response, neurotransmitter, or cellular-energy pathways.

However, the supplied information does not establish validated human safety, compatibility, efficacy, or dosing for these combinations.

They should therefore remain experimental research concepts rather than recommended stacks.


Atlas Longevity Semax Pen Dosage / Click Chart

The Atlas Longevity Semax pen contains:

30 mg Semax

3 mL cartridge volume

300 total clicks

1 click = 0.01 mL

Maximum selectable dial amount = 60 clicks

Pen Specification

Pen Strength Volume Concentration Amount Per Click
30 mg 3 mL 10 mg/mL 0.10 mg / 100 mcg

Concentration Calculation

30 mg ÷ 3 mL = 10 mg/mL

Amount Per Click

30 mg ÷ 300 clicks = 0.10 mg per click

Therefore:

1 click = 0.10 mg

or:

100 mcg Semax


Semax Click Conversion Chart

Clicks Volume Semax Amount
1 0.01 mL 0.10 mg / 100 mcg
2 0.02 mL 0.20 mg
3 0.03 mL 0.30 mg
4 0.04 mL 0.40 mg
5 0.05 mL 0.50 mg
6 0.06 mL 0.60 mg
9 0.09 mL 0.90 mg
10 0.10 mL 1.00 mg
12 0.12 mL 1.20 mg
15 0.15 mL 1.50 mg
20 0.20 mL 2.00 mg
30 0.30 mL 3.00 mg
40 0.40 mL 4.00 mg
50 0.50 mL 5.00 mg
60 0.60 mL 6.00 mg

Useful Conversions

  • 1 click = 0.10 mg
  • 3 clicks = 0.30 mg
  • 6 clicks = 0.60 mg
  • 10 clicks = 1 mg
  • 12 clicks = 1.20 mg
  • 30 clicks = 3 mg
  • 60 clicks = 6 mg

The maximum selectable amount in one dial operation is:

60 clicks = 0.60 mL = 6 mg Semax

This is a mathematical concentration conversion and not a dosing recommendation.


Protocol / Dosage Information

The supplied source describes experimental research quantities ranging approximately from 0.10 mg to 1.20 mg. Pasted text

Because the source product also uses 30 mg in 3 mL, its mathematical concentration happens to match the Atlas pen concentration.

However, all values were still independently recalculated using the Atlas standard:

30 mg ÷ 300 clicks = 0.10 mg per click

Source-Referenced Amount Atlas Pen Mathematical Equivalent
0.10 mg 1 click
0.20 mg 2 clicks
0.30 mg 3 clicks
0.60 mg 6 clicks
0.90 mg 9 clicks
1.20 mg 12 clicks

The supplied source also provides frequency, timing, duration, divided-dose, and cycling examples. Those should not be reproduced as self-administration instructions for the Atlas product.

These values simply translate research quantities into the Atlas concentration.


Possible Side Effects

The supplied material describes Semax as generally well tolerated in the research it references, but the available human evidence is limited.

Reported observations include:

  • headache;
  • light-headedness;
  • temporary changes in alertness;
  • temporary changes in sleep patterns;
  • mild fatigue;
  • restlessness;
  • localized redness at injection sites. Pasted text

The source also lists nasal irritation or burning, but that effect relates specifically to intranasal administration and should not automatically be transferred to the Atlas pen.

Long-Term Safety

The source states that significant hormonal, cardiovascular, or systemic adverse effects were not identified in the research it references.

However, it also acknowledges that long-term safety remains under investigation. Pasted text

Important uncertainties include:

  • prolonged systemic exposure;
  • interactions with psychiatric medications;
  • interactions with other neuroactive compounds;
  • neurological conditions;
  • cardiovascular effects not captured by limited studies;
  • pregnancy and reproductive exposure;
  • combination protocols.

Absence of adverse events in limited studies should not be interpreted as proof of complete safety.


Product Attributes

Attribute Information
Compound Name Semax
CAS Number 80714-61-0
Molecular Formula C37H51N9O10S
Amino Acid Sequence MEHFPGP
Peptide Length 7 amino acids
Molecular Weight 813.9 g/mol
PubChem CID 9811102
Half-Life listed by source Approximately 20–30 minutes for intranasal administration
Synonyms ACTH-fragment PGP analogue, Met-Glu-His-Phe-Pro-Gly-Pro, Semax acetate
Compound Type Synthetic ACTH-derived regulatory heptapeptide
Research Focus Cognition, neuroprotection, stress biology and neuroplasticity

These specifications are reported in the supplied reference material. Pasted text

Nomenclature Note

The supplied material uses more than one ACTH-fragment description for Semax.

At the beginning it describes Semax as derived from ACTH (4–10), while the synonym section later identifies it as ACTH (4–7) PGP. Pasted text Pasted text

Because the supplied amino-acid sequence is MEHFPGP, Atlas should confirm the exact nomenclature, salt form, and sequence against the actual product COA before publishing final technical specifications.

Included in the Box

Each Atlas Longevity product is carefully packed to support secure storage, clean handling, and convenient research use. Inside the package, you’ll find the essential items needed for organized laboratory handling:

  • 1× Ready-to-Use Injection Pen
  • 10× Ultra-Fine Needles (33G, 4 mm)
  • 10× Alcohol Prep Pads
  • Protective Foam Insert to help keep the pen secure during transport
  • Quick-Reference Instruction Panel inside the packaging
  • Tamper-Evident Security Seal for added package protection

Each component is arranged in a clean, protective presentation designed to keep the product secure and easy to access.

Storage

Storage conditions should follow the instructions supplied specifically with the Atlas Longevity Semax formulation.

The reference product provides refrigeration and stability specifications for its own finished formulation. Those conditions should not automatically be transferred to Atlas Longevity without formulation-specific stability evidence.

Follow the temperature requirements, light-protection guidance, handling instructions, and shelf-life information shown on the Atlas Longevity product label or accompanying documentation.


Frequently Asked Questions

What is Semax?

Semax is a synthetic regulatory heptapeptide derived from ACTH-fragment research.

It is primarily studied in relation to BDNF, neuroplasticity, cognition, neurotransmitter signalling, stress-response biology, and experimental neuroprotection. Pasted text

Is Semax ACTH?

No.

Semax is derived from ACTH-fragment research but is not full-length ACTH.

The supplied material describes Semax as having neurological activity without significant stimulation of adrenal corticosteroid production. Pasted text

How does Semax work?

Semax is studied for its potential influence on:

  • BDNF;
  • neurotrophic signalling;
  • synaptic plasticity;
  • dopamine;
  • serotonin;
  • neuronal-survival pathways;
  • stress-related gene expression. Pasted text

What is BDNF?

BDNF — brain-derived neurotrophic factor — is a protein involved in neuronal survival, synaptic plasticity, learning-related signalling, and adaptation of neural networks.

Changes in BDNF expression are one of the major areas of Semax research.

What is Semax researched for?

Research areas include:

  • neuroplasticity;
  • cognition;
  • attention;
  • memory;
  • stress resilience;
  • cerebral ischemia;
  • neuronal survival;
  • dopamine and serotonin signalling;
  • neuroimmune regulation.

Evidence strength differs substantially across these areas.

Has Semax been studied in humans?

Yes.

The supplied material describes regional clinical and observational research alongside animal and in-vitro studies. Pasted text

However, the supporting reference list supplied with the product is dominated by animal, in-vitro, and observational evidence. Pasted text

Is Semax approved for cognitive enhancement?

The supplied material does not establish broad regulatory approval of Semax as a cognitive-enhancement treatment.

It should therefore remain positioned as an investigational research peptide.

Is Semax a stimulant?

Semax is not described by the supplied material as a conventional stimulant.

Its proposed mechanisms involve neurotrophic and neurotransmitter-regulatory pathways rather than classic stimulant pharmacology.

Does Semax increase cortisol?

The source states that Semax does not significantly stimulate corticosteroid production like full ACTH. Pasted text

This should not be interpreted as proof that every formulation or exposure has no endocrine effects.

Is Semax researched for stroke recovery?

Yes.

The supplied material references clinical and preclinical research involving cerebral ischemia, neuronal survival, and neurological recovery. Pasted text

These studies do not establish the Atlas Semax pen as an approved stroke treatment.

Does Semax improve memory?

Some experimental research described by the source reports changes in memory, attention, and cognitive-performance measures.

The evidence is not sufficient to guarantee cognitive improvement in humans.

How much Semax is in each Atlas Longevity pen?

Each Atlas Longevity Semax pen contains:

30 mg Semax in 3 mL.

What is the concentration of the Semax pen?

The concentration is:

30 mg ÷ 3 mL = 10 mg/mL

How many clicks are in the Semax pen?

Each pen contains:

300 total clicks / units

with:

1 click = 0.01 mL

How much Semax is in one click?

Each click contains:

0.10 mg

or:

100 mcg Semax

How many clicks equal 0.3 mg?

3 clicks = 0.30 mg.

How many clicks equal 0.6 mg?

6 clicks = 0.60 mg.

How many clicks equal 0.9 mg?

9 clicks = 0.90 mg.

How many clicks equal 1.2 mg?

12 clicks = 1.20 mg.

How many clicks equal 3 mg?

30 clicks = 3 mg.

These values are mathematical concentration conversions rather than dosing recommendations.

What is the maximum selectable amount on the Semax pen?

The maximum single dial selection is:

60 clicks

which equals:

0.60 mL

and:

6 mg Semax

This describes pen mechanics rather than a recommended amount.

How long does a Semax pen last?

The complete pen contains:

300 clicks and 30 mg Semax.

The number of administrations depends on the number of clicks selected each time.

For cartridge-capacity calculations only:

  • 3 clicks at a time = 100 administrations
  • 6 clicks at a time = 50 administrations
  • 10 clicks at a time = 30 administrations
  • 12 clicks at a time = 25 administrations
  • 30 clicks at a time = 10 administrations
  • 60 clicks at a time = 5 administrations

These examples describe cartridge capacity rather than a treatment protocol.

Does the medication disappear when the dial returns to zero?

No.

After administration, the dial returns to zero while the unused formulation remains inside the cartridge.

The remaining Semax stays in the pen until all 300 units have been used.

What is the half-life of Semax?

The supplied source lists approximately 20–30 minutes, but specifically associates this figure with intranasal administration. Pasted text

That value should not automatically be treated as the established half-life of the Atlas pen formulation.

Can Semax be combined with Selank?

The supplied source discusses Semax + Selank as an experimental research concept involving complementary neurotrophic and stress-response pathways. Pasted text

Validated human combination safety, efficacy, compatibility, and dosing are not established by the supplied evidence.

Can Semax be combined with NAD+?

The source also describes Semax + NAD+ as an experimental concept involving neuronal energy and neuroplasticity research.

This remains a research concept rather than an established clinical combination.

Is there an established human dosage for the Atlas Semax pen?

The source describes experimental quantities, but it does not establish a universally accepted or approved dosing standard for the Atlas formulation.

The Atlas click chart therefore represents concentration mathematics only.

How should the Atlas Longevity Semax pen be stored?

Follow the storage instructions supplied specifically with the actual Atlas Longevity Semax formulation.

The reference manufacturer’s refrigeration and stability claims apply to its own finished product and should not automatically be transferred to Atlas without formulation-specific stability evidence.